Literature DB >> 22714648

Non-invasive quantification of coronary vascular dysfunction for diagnosis and management of coronary artery disease.

Venkatesh L Murthy1, Marcelo F Di Carli.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22714648      PMCID： PMC6526508          DOI： 10.1007/s12350-012-9590-1

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  19 in total

1.  In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE).

Authors:  Daniel F Pauly; B Delia Johnson; R David Anderson; Eileen M Handberg; Karen M Smith; Rhonda M Cooper-DeHoff; George Sopko; Barry M Sharaf; Sheryl F Kelsey; C Noel Bairey Merz; Carl J Pepine
Journal:  Am Heart J       Date:  2011-09-06       Impact factor: 4.749

2.  Improvement of myocardial blood flow to ischemic regions by angiotensin-converting enzyme inhibition with quinaprilat IV: a study using [15O] water dobutamine stress positron emission tomography.

Authors:  C A Schneider; E Voth; D Moka; F M Baer; J Melin; A Bol; R Wagner; H Schicha; E Erdmann; U Sechtem
Journal:  J Am Coll Cardiol       Date:  1999-10       Impact factor: 24.094

3.  Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy.

Authors:  Danilo Neglia; Renata De Maria; Stefano Masi; Michela Gallopin; Patrizia Pisani; Silvia Pardini; Antonello Gavazzi; Antonio L'abbate; Oberdan Parodi
Journal:  Heart       Date:  2007-01-19       Impact factor: 5.994

4.  Effect of beta 1 adrenergic receptor blockade on myocardial blood flow and vasodilatory capacity.

Authors:  M Böttcher; J Czernin; K Sun; M E Phelps; H R Schelbert
Journal:  J Nucl Med       Date:  1997-03       Impact factor: 10.057

5.  Transient ischemic dilation of the left ventricle on stress thallium-201 scintigraphy: a marker of severe and extensive coronary artery disease.

Authors:  A T Weiss; D S Berman; A S Lew; J Nielsen; B Potkin; H J Swan; A Waxman; J Maddahi
Journal:  J Am Coll Cardiol       Date:  1987-04       Impact factor: 24.094

6.  Prevalence of high-risk thallium-201 scintigraphic findings in left main coronary artery stenosis: comparison with patients with multiple- and single-vessel coronary artery disease.

Authors:  T W Nygaard; R S Gibson; J M Ryan; J A Gascho; D D Watson; G A Beller
Journal:  Am J Cardiol       Date:  1984-02-01       Impact factor: 2.778

7.  Angiotensin receptor blocker improves coronary flow velocity reserve in hypertensive patients: comparison with calcium channel blocker.

Authors:  Fumihiko Kamezaki; Hiromi Tasaki; Kazuhito Yamashita; Kiyoko Shibata; Noriko Hirakawa; Masato Tsutsui; Ryouji Kouzuma; Toshihisa Nagatomo; Tetsuo Adachi; Yutaka Otsuji
Journal:  Hypertens Res       Date:  2007-08       Impact factor: 3.872

8.  Telmisartan, an angiotensin II type 1 receptor blocker, improves coronary microcirculation and insulin resistance among essential hypertensive patients without left ventricular hypertrophy.

Authors:  Toshihide Hinoi; Yasuyuki Tomohiro; Shinji Kajiwara; Syusuke Matsuo; Yukihiro Fujimoto; Shu Yamamoto; Takeshi Shichijo; Tetuya Ono
Journal:  Hypertens Res       Date:  2008-04       Impact factor: 3.872

9.  Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X.

Authors:  Jaw-Wen Chen; Nai-Wei Hsu; Tao-Cheng Wu; Shing-Jong Lin; Mau-Song Chang
Journal:  Am J Cardiol       Date:  2002-11-01       Impact factor: 2.778

10.  Effect of angiotensin-converting enzyme inhibitor on serum asymmetric dimethylarginine and coronary circulation in patients with type 2 diabetes mellitus.

Authors:  Takayuki Kawata; Masao Daimon; Rei Hasegawa; Kiyomi Teramoto; Tomohiko Toyoda; Tai Sekine; Kyohei Yamamoto; Daigaku Uchida; Toshiharu Himi; Katsuya Yoshida; Issei Komuro
Journal:  Int J Cardiol       Date:  2008-02-20       Impact factor: 4.164
View more
  11 in total

Review 1.  Clinical use of quantitative cardiac perfusion PET: rationale, modalities and possible indications. Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM).

Authors:  Roberto Sciagrà; Alessandro Passeri; Jan Bucerius; Hein J Verberne; Riemer H J A Slart; Oliver Lindner; Alessia Gimelli; Fabien Hyafil; Denis Agostini; Christopher Übleis; Marcus Hacker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-02-05       Impact factor: 9.236

Review 2.  Proceedings of the Cardiac PET Summit, 12 May 2014, Baltimore, MD : 3: Quantitation of myocardial blood flow.

Authors:  Timothy M Bateman; K Lance Gould; Marcelo F Di Carli
Journal:  J Nucl Cardiol       Date:  2015-04-24       Impact factor: 5.952

3.  Dynamic SPECT: evolution of a widely available tool for the assessment of coronary flow reserve.

Authors:  Simona Ben-Haim; Denis Agostini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-02       Impact factor: 9.236

4.  Quantification of myocardial blood flow with PET: ready for clinical application.

Authors:  George A Beller
Journal:  J Nucl Cardiol       Date:  2012-10       Impact factor: 5.952

5.  Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC.

Authors:  Venkatesh L Murthy; Timothy M Bateman; Rob S Beanlands; Daniel S Berman; Salvador Borges-Neto; Panithaya Chareonthaitawee; Manuel D Cerqueira; Robert A deKemp; E Gordon DePuey; Vasken Dilsizian; Sharmila Dorbala; Edward P Ficaro; Ernest V Garcia; Henry Gewirtz; Gary V Heller; Howard C Lewin; Saurabh Malhotra; April Mann; Terrence D Ruddy; Thomas H Schindler; Ronald G Schwartz; Piotr J Slomka; Prem Soman; Marcelo F Di Carli; Andrew Einstein; Raymond Russell; James R Corbett
Journal:  J Nucl Cardiol       Date:  2018-02       Impact factor: 5.952

Review 6.  Sex-Specific Disparities in Risk Factors for Coronary Heart Disease.

Authors:  Stacey E Rosen; Sonia Henry; Rachel Bond; Camille Pearte; Jennifer H Mieres
Journal:  Curr Atheroscler Rep       Date:  2015-08       Impact factor: 5.113

7.  Effects of sex on coronary microvascular dysfunction and cardiac outcomes.

Authors:  Venkatesh L Murthy; Masanao Naya; Viviany R Taqueti; Courtney R Foster; Mariya Gaber; Jon Hainer; Sharmila Dorbala; Ron Blankstein; Ornella Rimoldi; Paolo G Camici; Marcelo F Di Carli
Journal:  Circulation       Date:  2014-04-30       Impact factor: 29.690

8.  An Open Benchmark Challenge for Motion Correction of Myocardial Perfusion MRI.

Authors:  Beau Pontre; Brett R Cowan; Edward DiBella; Sancgeetha Kulaseharan; Devavrat Likhite; Nils Noorman; Lennart Tautz; Nicholas Tustison; Gert Wollny; Alistair A Young; Avan Suinesiaputra
Journal:  IEEE J Biomed Health Inform       Date:  2017-09       Impact factor: 5.772

9.  Coronary Microvascular Dysfunction in Rheumatoid Arthritis Compared to Diabetes Mellitus and Association With All-Cause Mortality.

Authors:  Katherine P Liao; Jie Huang; Zeling He; Gabrielle Cremone; Ethan Lam; Jon M Hainer; Victoria Morgan; Courtney Bibbo; Marcelo Di Carli
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-02       Impact factor: 4.794

10.  Assessment of global myocardial perfusion reserve using cardiovascular magnetic resonance of coronary sinus flow at 3 Tesla.

Authors:  Vineet K Dandekar; Michael A Bauml; Andrew W Ertel; Carolyn Dickens; Rosalia C Gonzalez; Afshin Farzaneh-Far
Journal:  J Cardiovasc Magn Reson       Date:  2014-03-27       Impact factor: 5.364
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.